𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical Presentation and Diagnosis of Intestinal Adenocarcinoma in Crohn’s Disease: Analysis of Clinical Predictors and of the Life-Time Risk

✍ Scribed by Cesare Ruffolo; Marco Scarpa; Lino Polese; Francesco E. D’Amico; Riccardo Boetto; Anna Pozza; Renata D’Incà; Davide Checchin; Giacomo Carlo Sturniolo; Nicolò Bassi; Imerio Angriman

Publisher
Springer-Verlag
Year
2010
Tongue
English
Weight
132 KB
Volume
14
Category
Article
ISSN
1091-255X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective evaluation of the clinical u
Prospective evaluation of the clinical utility of interferon-γ assay in the differential diagnosis of intestinal tuberculosis and Crohn's disease
✍ Beom Jin Kim; Yong Sung Choi; Byung Ik Jang; Young Sook Park; Won Ho Kim; You Su 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Background: Distinguishing intestinal tuberculosis (ITB) from Crohn's disease (CD) is challenging. This study prospectively evaluated the clinical utility of the QuantiFERON-TB gold test (QFT) in the differential diagnosis of ITB and CD, and compared it with the clinical utility of the tuberculin sk

Predictive model for the outcome of infl
Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors
✍ Tibor Hlavaty; Marc Ferrante; Liesbet Henckaerts; Marie Pierik; Paul Rutgeerts; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Background: Infliximab (ifx) is an effective therapy for refractory luminal and fistulizing crohn's disease (cd). predictors of response could improve selection of patients with a higher probability of favorable outcomes and could improve the safety profile. we aimed to develop a predictive mode